ArticleGalen medical journal2024
Evaluation of Risk Factors Related to Ovarian Involvement in Endometrial Cancer Patients: A Retrospective Study.
Article in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometrial cancer (EC) is a cancer that occurs in women. This study aimed to determine the risk factors of Ovarian involvement (OI) in patients with EC and define the risk of developing an associated malignancy during follow-up after EC treatment. MATERIALS AND
methodsThis retrospective study (n=280) was conducted to determine the risk factors of OI following EC in female patients with a definitive diagnosis of uterine cancer admitted to Imam Khomeini Hospital in Tehran over the preceding 15 years, between 2010 and 2024. We evaluated the roles of risk factors for OI, such as age, histological subtype, tumor grade, myometrial infiltration, tumor diameter, cervical infiltration, lympho vascular space invasion (LVSI), and positive peritoneal cytology for malignancy (P.P.C).
resultsThe results showed that there was a relationship between the risk factors of myometer, LVSI, cervix, serous, tube, intra-abdominal, complaint, lymph node and omentum between the two groups with and without OI (P0.05). Based on Univariate and Multiple Analysis, the results showed that Omentum Involvement, P.P.C and Serous Carcinoma were related to OI. Also, based on multivariate logistic regression The results confirmed that the following predictors were correlated with OI: P.P.C (OR=8.54, 95% CI=1.52_47.88, P-value=0.015), omentum involvement (OR=10.82, 95% CI=2.21_52.82, P-value=0.03), and serous carcinoma (OR=4.41, 95% CI=1.44_13.53, P-value 0.009).
conclusionMyometer, LVSI, cervix, serous, tube, intra-abdominal, complaint, lymph node and omentum factors were related to OI. Evaluation of risk factors plays an important role in the management of EC patients who are exposed to ovarian metastasis, therefore, the diagnosis of risk factors can be helpful in treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.